Acute inhibition of insulin receptors in the periphery vs. the brain produced different cytokine and blood-brain barrier responses to inflammation, with implications for neurodegeneration.
Location-dependent responsesPeripheral vs. central insulin resistance produces distinct brain barrier and inflammatory patterns
What the researchers found
Peripheral and central insulin receptor inhibition produce distinct cytokine and BBB responses to inflammation, suggesting location-specific mechanisms linking insulin resistance to neurodegeneration.
Why it matters
Understanding whether peripheral or central insulin resistance drives BBB disruption could guide therapeutic strategies for preventing neurodegeneration in metabolic disease.
How the study worked
Preclinical study examining acute peripheral vs. central insulin receptor blockade followed by inflammatory challenge, with measurement of cytokine profiles and BBB integrity.
What this study cannot tell us
Acute insulin receptor blockade may not perfectly model chronic insulin resistance; animal model; translational relevance to human conditions needs validation.
How to read the evidence
Preclinical mechanistic study — provides important conceptual insight but needs clinical translation.
When this study was published
Published 2026 in Brain, Behavior, and Immunity.
The bigger picture
This study bridges metabolic and neurodegenerative disease, showing how the location of insulin resistance specifically shapes brain vulnerability.
Questions still open
- Do GLP-1 RAs that cross the BBB protect against central insulin resistance-driven neurodegeneration?
- Should metabolic therapies target peripheral vs. central insulin resistance differently?
Common questions
How is insulin resistance in the brain different from the body?
Could this explain why diabetes increases dementia risk?
Read the original research
Acute peripheral versus central inhibition of insulin receptors differentially alters cytokine and blood-brain barrier responses to an inflammatory stimulus.
Brain, behavior, and immunity, 133, 106251
Citation
Bandarupalli, Tanmai; Noonan, Cassidy; Hansen, Kim; Weaver, Riley; Baumann, Kristen; Banks, William A; Erickson, Michelle A; Rhea, Elizabeth M. (2026). Acute peripheral versus central inhibition of insulin receptors differentially alters cytokine and blood-brain barrier responses to an inflammatory stimulus.. Brain, behavior, and immunity, 133, 106251. https://doi.org/10.1016/j.bbi.2025.106251